Fulcrum Therapeutics Inc. (FULC) Tops Q1 EPS by 5c

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q1 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Trifecta Gold closes $1.66M private placement for Yukon exploration
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank